Industry Research Reports and Market Analysis at MindBranch.com Research Index | Publishers | My Account | Contact Us | About MindBranch
Welcome Guest  (Login/Register) |  0 items
  
Advanced Search > | Tips >
Contact a
Research Assistant

US 800-774-4410
or +1-240-747-3094

Search Assistance >

Home  > Healthcare  >  Biotechnology  >  General Biotech

Regentis Biomaterials Ltd. Product Pipeline Analysis


Published Date: August 2008
Published By: Global Markets Direct
Page Count: 19
Order Code: R3480-5749
 
DescriptionTable of ContentsSimilar
Products

Regentis Biomaterials Ltd. Product Pipeline Analysis

Summary

This report is an insightful source for data, analysis and strategic insights into a Regentis Biomaterials Ltd.’s pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope
  • Details of development stage by sector and equipment type.
  • Pipeline products grouped by therapy area, development stage and trial phase.
  • Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
  • Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
  • Product updates covering estimated approval dates and estimated launch dates.
  • Descriptions of novel technologies relating to pipeline products of the company.
  • Patents and patent applications covered for the product.
  • News updates on key events relating to the product and its development.
Reasons to buy
  • A single source to fulfill competitor information relating to products in development.
  • Identify pipeline products that are potential competitor to your product lines.
  • Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.
  • Access clinical trial information to map trial results and plan targeted marketing activities.
  • Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
  • Identification of potential investment opportunities.
  • Build up knowledge base for potential distribution and marketing partners.
  • Helps avoid patent infringement.
  • Timelines from concept to market lets you keep track of market potential build for a new product.
  • Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Similar Products
Biophotonics: A Strategic Assessment of Photonics Technologies for Biomedical Applications, 2nd Edition
Published Dec 2008 by Kalorama Information


MarketWatch: Biotechnology
Published Nov 2008 by Datamonitor


Biodetection Technologies 5th Edition
Published Nov 2008 by Knowledge Foundation


Effective Competitive Intelligence: A "How-To" Guide for Life Science Companies
Published Nov 2008 by Kalorama Information


13th Annual International Detection Technologies 2008 Conference Documentation
Published Nov 2008 by Knowledge Foundation


Biotechnology in the US - Industry Risk Rating Report
Published Oct 2008 by IBISWorld


Cell Therapeutics Inc - SWOT Analysis
Published Oct 2008 by Datamonitor


Biogen Idec, Inc. - SWOT Analysis
Published Oct 2008 by Datamonitor


ZymoGenetics, Inc. - SWOT Analysis
Published Oct 2008 by Datamonitor


Gilead Sciences, Inc. - SWOT Analysis
Published Oct 2008 by Datamonitor




 


Privacy Policy | Terms & Conditions | Site Map | Return Policy | Help FAQs
Copyright © 1999-2008, All Rights Reserved, MindBranch.com
Trust-e Logo
Phone: 800-774-4410 (US) or +1-240-747-3094 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: support@mindbranch.com